rs1553176630
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_022114.4(PRDM16):c.1819_1823delGTCAAinsTTCAT(p.ValAsn607PheIle) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Left ventricular noncompaction 8 Uncertain:1
This variant has not been reported in the literature in individuals with a PRDM16-related disease. This variant is not present in population databases (ExAC no frequency). This variant, c.1819_1823delinsTTCAT, is a complex sequence change that deletes five nucleotides and inserts five nucleotides resulting in the deletion of valine and asparagine and the insertion of phenylalanine and isoleucine in the PRDM16 protein (p.Val607_Asn608delinsPheIle). Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted and inserted amino acids is currently unknown. In summary, this variant has uncertain impact on PRDM16 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at